Strategic Blueprint’s ResMed RMD Stock Holding History

Strategic Blueprint’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-56	Closed	-$14K	–	1119
2021 Q2	$14K	Buy	+56	New	+$11.8K	﹤0.01%	903
2019 Q4	–	Sell	-56	Closed	-$8K	–	345
2019 Q3	$8K	Buy	+56	New	+$7.34K	0.01%	322

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Strategic Blueprint's RMD Position: Q3 2021 in Review

Strategic Blueprint sold out of ResMed (RMD) in Q3 2021, closing a stake of 56 shares — an estimated $14K sold.

Strategic Blueprint first reported a position in RMD in Q3 2019 and held it in 2 quarters. The position peaked at $14K in Q2 2021. 686 funds tracked by Wall St. Rank hold RMD as of Q3 2021.

Strategic Blueprint reported no remaining ResMed position as of Q3 2021 after selling out during the quarter.
Strategic Blueprint sold 56 ResMed shares in Q3 2021, an estimated $14K.
Strategic Blueprint first reported a position in ResMed in Q3 2019 and held it in 2 quarters.
Strategic Blueprint's ResMed position peaked at $14K in Q2 2021.
686 funds tracked by Wall St. Rank held ResMed as of Q3 2021.

Based on Strategic Blueprint's 13F filing for Q3 2021, filed 12 Nov 2021.